News

Ancestry.com is currently beta testing its new feature designed to connect personal DNA reports with family trees and provide its users with more information regarding their lineages and ethnicity profiles. Read all about this exciting new addition and find out how to test the beta version of ThruLines in this short report.

MyHeritage has just released a new feature called AutoClusters that groups different genetic relatives discovered by your DNA sequencing into clusters with the same shared ancestor. Apart from providing you with a clearer final report, this tech will also give you better explanations of each individual connection. Read more in this article.

MyHeritage has just introduced a groundbreaking new technology called the Theory of Family Relativity that aims to combine billions of historical records with millions of family trees in order to better explain the biological DNA connections shown by its at-home DNA tests. Read more in this short overview.

Ancestry has just released new data relevant to individuals from the African diaspora. Its users received 94 new and updated communities, which should reveal new information about the genetic roots of African Americans and Afro-Caribbeans as well as the migration patterns of their ancestors through history. Read more in this short report.

23andMe’s genetic database provided the necessary samples for the latest study related to genetic prerequisites for low bone density and the development of osteoporosis. The main goal of the study was to find the causal connection between the genetic variations and the illness and help develop potential treatments and identify patients earlier.

After clearing its test for three variants in BRCA1 and BRCA2 genes related to breast cancer, the FDA has also greenlit 23andMe’s test for two variants that influence MUTYH-associated polyposis. This is a rare condition that generally increases the risk of developing colorectal cancer. Learn more about this test in our report.

23andMe has partnered with Lark Health to incorporate 8 health-related reports into its wellness AI-based coach app in order to help people lose weight based on their genetics. Learn more in this article.

Embark Dog DNA Test has officially made it to this year’s Oprah’s Favorite Things gift list and it is featured in the December issue of O, The Oprah Magazine. Read this article to learn more about Embark and find out how you can win some or even all the items on this list packed with crazy gadgets, delicious cakes, and more.

23andMe’s Personal Genome Service Pharmacogenetic Reports test just got approved by the FDA. The first direct-to-customer screening option of its kind to secure FDA approval, the test is designed to detect potential genetic variants in charge of one’s ability to metabolize certain medications. Learn more about this big win for 23andMe in this article.

Embark has published its first scientific research, which conveys the company’s commitment to ending all preventable diseases in dogs. The project, which is the biggest initiative of its kind to date, was launched to answer why some dogs have blue eyes. Learn more about this exciting genome-wide association study in this article.